Table 4.

Histopathological features and outcomes in 19 HCC patients with BDTT

Patient No.	Age (years)	Sex	Cirrhosis	No. of tumors	Largest size (cm)	Diff.	Margin	V.inv	Lym/neu. Inv.	Recur.	Survival (months)	Outcome	Cause of death
1	51	M	Present	1	5	Poor	Positive	(+)	(−)	IH, EH	11	Died	Cancer
2	35	M	Present	1	6	Moderate	Free	(+)	(−)	IH	22	Died	Cancer
3	60	M	Absent	1	4	Well	Free	(+)	(−)	(−)	132	Alive	–
4	42	M	Present	1	6	Moderate	Free	(+)	(−)	(−)	104	Alive	–
5	76	M	Absent	1	2.5	Moderate	Free	(+)	(−)	(−)	84	Alive	–
6	57	M	Present	1	5.5	Moderate	Free	(+)	(−)	(−)	65	Alive	–
7	44	M	Present	3	3.5	Well	Free	(+)	(−)	(−)	60	Alive	–
8	39	M	Present	2	7.5	Moderate	Positive	(−)	(+)	IH, EH	17	Died	Cancer
9	46	M	Absent	1	8.5	Poor	Free	(+)	(−)	(−)	32	Alive	–
10	51	M	Present	1	7.5	Poor	Positive	(+)	(−)	IH, EH	4	Died	Cancer
11	55	F	Absent	1	19	Moderate	Free	(+)	(+)	EH	19	Alive	–
12	50	M	Absent	2	5	Moderate	Positive	(+)	(−)	IH	16	Alive	–
13	40	F	Absent	3	12	Well	Positive	(+)	(−)	IH	10	Alive	–
14	50	M	Absent	1	7.5	Well	Free	(+)	(−)	IH	11	Alive	–
15	74	M	Present	1	2.5	Moderate	Free	(−)	(−)	EH	7	Alive	–
16	47	F	Present	1	4	Moderate	Free	(+)	(−)	(−)	5	Alive	–
17	48	M	Present	1	5	–	–	–	–	–	2	Died	Sepsis
18	52	F	Present	1	5	–	–	–	–	–	2	Died	Liver failure
19	48	M	Present	1	2.2	–	–	–	–	–	7	Alive	–

Abbreviations: HCC, hepatocellular carcinoma; BDTT, bile duct tumor thrombus; IH, intrahepatic recurrence; EH, extrahepatic recurrence; M, male; F, female; Diff., differentiared; V.inv, venous invasion; Lym/neu. inv., lymphatic/neural invasion; Recur, recurrence.